Trial intelligence / Profile preview

Ondansetron in opium-dependent surgical patients under general anesthesia

IRCT2017051333940N1Phase 3Completed

Sponsor
Pharmaceutical Research Center
Start
May 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ondansetron, sponsored by Pharmaceutical Research Center. Started May 2017; status: completed.

02

Drugs

ondansetron

Beyond the preview

Go deeper on IRCT2017051333940N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017051333940N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call